Renaissance Capital logo

Health Care IPOs

The healthcare sector naturally includes companies that provide healthcare services, manufacture and distribute healthcare equipment & supplies, and healthcare technology. It includes companies that research, develop, produce and market pharmaceuticals, biotechnology products, genetic tests, and medical devices.

Research Health Care IPOs

The healthcare sector represents a key pillar of the IPO market, largely due to the amount of venture funding that pours into the development of new drug candidates, medical devices, and diagnostics and screening tools. Biotech investing is a high-risk endeavor, due to the fact that so many drug candidates fail to reach FDA approval. Investors often face one of two outcomes: either the drug is approved and the stock does well, or it is rejected and the stock plummets.

With that backdrop, prospective biotech investors examine the clinical results to date, the phase of ongoing clinical trials, the amount of private funding from reputable investors, and management's experience. Valuing a biotech or device company is more art than science, and investors often compare an IPO to the market cap of similar development-stage companies or an estimate of peak sales for a potential new drug. In addition to riskier early-stage companies, the healthcare sector also features defensive stocks that provide necessary services regardless of the economic environment, including profitable hospitals, pharmaceuticals, and healthcare research, manufacturing, and service providers.

Image for health care research

Upcoming Health Care IPOs

Research upcoming health care IPOs this month with our IPO Calendar.

There are no scheduled Health Care IPOs. Check out the IPO Calendar to see upcoming IPOs from all sectors, or view the full pipeline of Health Care IPOs with a free trial of IPO Pro.

Health Care IPOs This Year

Research IPOs in the health care industry this year. Our Recently Priced IPOs page allows you to research health care stocks and various IPO metrics. Access advanced industry screening on IPO Pro.

Ticker Company Ticker Offer Date Deal Size ($M) Current Price Today's Change Return from IPO
CUPR Cuprina Holdings CUPR 04/09/25 $12 $4.90
$+0.05
(1.0%)
22.5%
NTHI NeOnc Technologies NTHI 03/26/25 $ $7.51
$+0.17
(2.3%)
-53.1%
ADVB Advanced Biomed ADVB 03/05/25 $7 $1.05
$+0.10
(10.7%)
-73.8%
KMTS Kestra Medical Tech KMTS 03/05/25 $202 $23.29
$+0.62
(2.7%)
37.0%
BMGL Basel Medical BMGL 02/24/25 $9 $4.78
$0.00
(0.0%)
19.5%
NNNN Anbio NNNN 02/18/25 $8 $6.80
$+0.37
(5.8%)
36.0%
AARD Aardvark Therapeutics AARD 02/12/25 $94 $10.40
$-0.02
(-0.2%)
-35.0%
SION Sionna Therapeutics SION 02/06/25 $191 $12.71
$+0.39
(3.1%)
-29.4%
MAZE Maze Therapeutics MAZE 01/30/25 $140 $10.04
$+0.42
(4.4%)
-37.3%
MTSR Metsera MTSR 01/30/25 $275 $24.58
$+0.71
(3.0%)
36.6%
BBNX Beta Bionics BBNX 01/29/25 $204 $14.58
$+0.63
(4.5%)
-14.2%
AAPG Ascentage Pharma AAPG 01/23/25 $126 $23.88
$-0.43
(-1.8%)
38.4%
ZYBT Zhengye Biotechnology ZYBT 01/06/25 $6 $10.05
$-0.26
(-2.5%)
151.3%

Important IPOs in the Health Care Industry

These IPOs either had significant industry buzz, large capital raises, or strong results.
These stocks are a sample of companies that you can research further using our IPO Pro tools.

RayzeBio logo
RayzeBio (RYZB)
  • Phase 3 biotech developing radiopharmaceutical therapies for cancer.
  • IPO Date: 09/14/23
  • IPO Deal Size: $311 million
  • Return from IPO: 247.2%
BrightSpring Health logo
BrightSpring Health (BTSG)
  • Provides home and community-based healthcare services.
  • IPO Date: 01/25/24
  • IPO Deal Size: $693 million
  • Return from IPO: 76.9%
Avantor logo
Avantor (AVTR)
  • LBO'd distributor and manufacturer of laboratory supplies and services.
  • IPO Date: 05/16/19
  • IPO Deal Size: $2,898 million